SIGA Technologies
SIGA
#8419
Rank
NZ$0.48 B
Marketcap
NZ$6.76
Share price
3.76%
Change (1 day)
-38.73%
Change (1 year)

Earnings for SIGA Technologies (SIGA)

Earnings in 2025 (TTM): NZ$0.15 Billion

According to SIGA Technologies's latest financial reports the company's current earnings are NZ$0.17 Billion. In 2024 the company made an earning of NZ$0.12 Billion a decrease over its 2023 earnings that were of NZ$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for SIGA Technologies from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.15 B26.17%
2024 NZ$0.12 B-16.31%
2023 NZ$0.14 B89.48%
2022 NZ$77.26 M-50.38%
2021 NZ$0.15 B16.22%
2020 NZ$0.13 B1268.64%
2019 NZ$9.78 M-98.69%
2018 NZ$0.74 B-1912.24%
2017 -NZ$41.27 Million-7.91%
2016 -NZ$44.81 Million-30.38%
2015 -NZ$64.36 Million-82.62%
2014 -NZ$0.38 Billion796.54%
2013 -NZ$41.3 Million5.18%
2012 -NZ$39.27 Million-28.53%
2011 -NZ$54.94 Million
2009 -NZ$20.8 Million35.95%
2008 -NZ$15.3 Million17.07%
2007 -NZ$13.07 Million9.58%
2006 -NZ$11.93 Million168.94%
2005 -NZ$4.44 Million-71.48%
2004 -NZ$15.55 Million67.71%
2003 -NZ$9.27 Million57.35%
2002 -NZ$5.9 Million3.73%
2001 -NZ$5.68 Million-54.2%
2000 -NZ$12.41 Million105.09%
1999 -NZ$6.05 Million-33.58%
1998 -NZ$9.11 Million477.78%
1997 -NZ$1.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-NZ$1.23 Billion-877.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$0.81 B 414.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.51 Billion-418.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-NZ$14.23 Million-109.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$0.46 B 196.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B 83.08%๐Ÿ‡บ๐Ÿ‡ธ USA